Reporting Manager
Adage Capital Management, L.P.
Symbol
MREO
Shares outstanding
775,357,028 shares
Disclosed Ownership
43,575,065 shares
Ownership
5.6%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2025, 09:34:55 UTC
Date of event
31 Dec 2024

Sponsored

Quoteable Key Fact

"ADAGE CAPITAL PARTNERS GP, L.L.C. disclosed 5.6% ownership in Mereo BioPharma Group plc Ordinary Shares, nominal value 0.003 GBP per share (MREO) on 31 Dec 2024."

Quick Takeaways

  • ADAGE CAPITAL PARTNERS GP, L.L.C. filed SCHEDULE 13G/A for Mereo BioPharma Group plc Ordinary Shares, nominal value 0.003 GBP per share (MREO).
  • Disclosed ownership: 5.6%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Feb 2025, 09:34.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adage Capital Management, L.P. 5.6% 43,575,065 0 43,575,065 /s/ Robert Atchinson By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Adage Capital Partners GP, L.L.C. 0% 0 0 0 /s/ Robert Atchinson By: Adage Capital Advisors, L.L.C., its Managing Member, By: Robert Atchinson, its Managing Member
Robert Atchinson 5.6% 43,575,065 0 43,575,065 /s/ Robert Atchinson Robert Atchinson, individually
Phillip Gross 5.6% 43,575,065 0 43,575,065 /s/ Phillip Gross Phillip Gross, individually